Japan
The University of Osaka - Department of Molecular Virology
SARS-CoV-2, Coronavirus COVID-19, Antibody-dependent enhancement, FcγR-mediated enhancement, FcγRII
COVID-19, DNA vaccine, adjuvant, antibody, T cell activation, neutralization activity
SARS-CoV-2; COVID-19; cellular immunity; spike protein; receptor-binding motif; mink; zoonosis; naturally occurring variants; B.1.427/429; B.1.298; L452R; Y453F
SARS-CoV-2, reverse genetics, infectious clone, CPER, mutagenesis, HiBiT